WST (WST) Stock Analysis

WST (WST) is a publicly traded company in the HEALTHCARE sector. It trades at $312.28, carries a market capitalization of $22.35B, a price-to-earnings ratio of 42.40. This page summarizes the public market data, fundamentals, and frequently asked questions for WST, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NYSE

Key Metrics

• Price: $312.28
• Market Cap: $22.35B
• P/E Ratio: 42.40
• EPS: $7.46
• 52-Week High: $330.88
• 52-Week Low: $206.12

Market Sentiment

WST currently has a Bullish sentiment score of 0.27.

About WST

West Pharmaceutical Services, Inc. (WST) is a premier provider of innovative injectable pharmaceutical packaging and delivery solutions, serving a diverse global healthcare market. Based in Exton, Pennsylvania, West is dedicated to enhancing drug delivery systems by offering integrated solutions that prioritize safety, reliability, and efficacy. The company collaborates closely with pharmaceutical and biotechnology firms, leveraging cutting-edge technology and quality assurance practices to o...

GNG Research Analysis

GNG Research scores WST (WST) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for WST.

Frequently Asked Questions

Does WST pay dividends?

WST (WST) does not currently pay a regular dividend.

What is WST's P/E ratio?

WST has a price-to-earnings (P/E) ratio of 42.40.

What is WST's market cap?

WST (WST) has a market capitalization of $22.35B with a current stock price of $312.28.